VASAPOLLO, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 7.472
AS - Asia 1.714
EU - Europa 1.228
SA - Sud America 308
AF - Africa 25
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 10.760
Nazione #
US - Stati Uniti d'America 7.425
SG - Singapore 1.118
IT - Italia 430
CN - Cina 274
BR - Brasile 258
DE - Germania 134
IE - Irlanda 125
HK - Hong Kong 108
PL - Polonia 102
RU - Federazione Russa 83
UA - Ucraina 72
VN - Vietnam 70
FR - Francia 61
GB - Regno Unito 61
NL - Olanda 37
SE - Svezia 37
FI - Finlandia 34
CA - Canada 24
AR - Argentina 23
JP - Giappone 20
CZ - Repubblica Ceca 19
ID - Indonesia 18
KR - Corea 18
MX - Messico 17
BD - Bangladesh 15
IN - India 15
TR - Turchia 12
AU - Australia 9
IQ - Iraq 9
BE - Belgio 7
EC - Ecuador 7
ES - Italia 7
ZA - Sudafrica 7
IR - Iran 5
MA - Marocco 5
NP - Nepal 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CO - Colombia 4
DZ - Algeria 4
PK - Pakistan 4
AT - Austria 3
CL - Cile 3
HU - Ungheria 3
IL - Israele 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GT - Guatemala 2
KE - Kenya 2
LT - Lituania 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
GR - Grecia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MR - Mauritania 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.760
Città #
Woodbridge 1.699
Wilmington 1.680
Houston 1.524
Singapore 348
Fairfield 240
Chandler 218
Ashburn 180
Ann Arbor 159
Dublin 125
Rome 113
Beijing 112
Hong Kong 108
New York 99
Kraków 93
Seattle 89
Council Bluffs 88
Cambridge 87
Los Angeles 76
Medford 62
Zhengzhou 52
Cedarhurst 50
Dearborn 50
Jacksonville 49
The Dalles 49
Dallas 43
Boardman 41
Santa Clara 41
Ho Chi Minh City 31
Milan 30
São Paulo 29
Lawrence 28
Buffalo 26
Monte Vista 21
Redondo Beach 21
North Bergen 20
Chicago 18
Naples 18
Olomouc 17
Hanoi 16
San Diego 16
Moscow 15
Bologna 14
Helsinki 13
Munich 13
Shanghai 13
Phoenix 12
Boston 11
Florence 11
Mülheim 11
San Francisco 11
Tokyo 11
Turin 11
London 10
Rio de Janeiro 10
Stockholm 10
Amsterdam 9
Brooklyn 9
Montreal 9
Salt Lake City 9
Ascoli Piceno 8
Denver 8
Melbourne 8
Atlanta 7
Brussels 7
Guangzhou 7
Manchester 7
Poplar 7
Redwood City 7
Ankara 6
Orem 6
Warsaw 6
Baghdad 5
Belo Horizonte 5
Curitiba 5
Dhaka 5
Johannesburg 5
Lappeenranta 5
Manaus 5
Mexico City 5
Querétaro 5
Quito 5
São José dos Campos 5
Augusta 4
Baku 4
Campinas 4
Chennai 4
Detroit 4
Engelhard 4
Menlo Park 4
Monte Porzio Catone 4
Mumbai 4
Ninh Bình 4
Norwalk 4
Nuremberg 4
Odawara 4
Porto Alegre 4
Ribeirão Preto 4
San Mateo 4
Seoul 4
Toronto 4
Totale 8.189
Nome #
Are Gestational and Essential Hypertension Similar? Left Ventricular Geometry and Diastolic Function 522
Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications 508
Body composition during normal pregnancy: reference ranges 494
Abnormal maternal cardiac function precedes the clinical manifestation of fetal growth restriction 487
Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies 477
Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy. A key for the prevention of preeclampsia 446
Left ventricular midwall mechanics at 24 weeks' gestation in high-risk normotensive pregnant women: Relationship to placenta-related complications of pregnancy 437
Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery 415
Maternal total vascular resistance and concentric geometry: A key to identify uncomplicated gestational hypertension 411
The computerized fetal heart rate analysis in post-term pregnancy identifies patients at risk for fetal distress in labour 408
Screening for preeclampsia in the first trimester: role of maternal hemodynamics and bioimpedence in non obese patients 384
Nifedipine-induced changes in body composition in hypertensive patients at term 369
Total body water estimation and maternal cardiac systolic function assessment in normal and gestational hypertensive pregnant women 347
Maternal body composition at term gestation and birth weight: is there a link? 346
Maternal cardiac systolic function and total body water estimation in normal and gestational hypertensive women 339
Foetal heart rate deceleration with combined spinal-epidural analgesia during labour: A maternal haemodynamic cardiac study 250
Correlation between maternal body composition and haemodynamic changes in pregnancy: different profiles for different hypertensive disorders 177
Fetal growth restriction and maternal cardiac function 173
Maternal hemodynamics early in labor: a possible link with obstetric risk? 159
Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Pre-Eclampsia and Italian Society of Perinatal Medicine 151
Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics 151
Hemodynamic guided treatment of hypertensive disorders in pregnancy: is it time to change our mind? 143
Restricted physical activity in pregnancy reduces maternal vascular resistance and improves fetal growth 137
Preterm delivery and elevated maternal total vascular resistance: signs of suboptimal cardiovascular adaptation to pregnancy? 136
Friendly help for clinical use of maternal hemodynamics 134
Pregnancy complications in chronic hypertensive patients are linked to pre-pregnancy maternal cardiac function and structure 133
Persistent maternal cardiac dysfunction after preeclampsia identifies patients at risk for recurrent preeclampsia 132
Hemodynamic Prediction and Stratification of Hypertensive Disorders of Pregnancy: A Dream That Is Coming True? 129
Effect of a nitric oxide donor on maternal hemodynamics in fetal growth restriction 112
Distinction between SGA and FGR by means of fetal umbilical vein flow and maternal hemodynamics 102
Fetal Umbilical Vein Flow in the Classification of Fetuses with Growth Restriction 97
Prenatal and postnatal imaging of multiple intracranial lipomas: Report of a Case 97
Early and Late preeclampsia: Two different maternal hemodynamic states in the latent phase of the disease 90
Cardiac Function 88
Systemic vascular resistance may influence the outcome of in vitro fertilization 84
Hemodynamic maladaptation and left ventricular dysfunction in chronic hypertensive patients at the beginning of gestation and pregnancy complications: a case control study 82
Hemodynamic assessment in patients with preterm premature rupture of the membranes (pPROM) 79
Restricted physical activity in pregnancy reduces maternal vascular resistance and improves fetal growth 76
Are Chlamydia Trachomatis and Neisseria Gonorrhoeae Screenings in Pregnant Women Being Properly Performed? A Single-Center Retrospective Observational Study in Italy 73
G2. Low pregestational fat mass and subsequent maternal cardiovascular maladaptation in early pregnancy. The missing link for preeclampsia 71
D2. Screening of preeclampsia (PE) in the first trimester: high total vascular resistance (TVR) with a reduced fat mass increase the risk in normo BMI patients 69
Screening for pre-eclampsia in the first trimester: role of maternal hemodynamics and bioimpedance in non-obese patients 68
Correlation between maternal body composition and haemodynamic changes in pregnancy: different profiles for different hypertensive disorders 66
Maternal peripheral vascular resistance at mid gestation in chronic hypertension as a predictor of fetal growth restriction 65
The “Preeclampsia and Hypertension Target Treatment” (“PYTT”) study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings 65
F1. Is there a correlation between total body water distribution and haemodynamic changes during pregnancy? 63
C-peptide and insulin levels at 24-30 weeks' gestation: An increased risk of adverse pregnancy outcomes? 58
Definition, identification, implications and management of hypodynamic hypertension in pregnancy 57
Preterm delivery and elevated maternal total vascular resistance: signs of suboptimal cardiovascular adaptation to pregnancy? 56
Maternal cardiovascular profile is altered in the preclinical phase of normotensive early and late intrauterine growth restriction 54
G1. Maternal haemodynamics assessment in preterm delivery: two different haemodynamic profiles 54
SARS-CoV-2, Endothelial Dysfunction, and the Renin-Angiotensin System (RAS): A Potentially Dangerous Triad for the Development of Pre-Eclampsia 50
Maternal hemodynamics for the identification of early fetal growth restriction in normotensive pregnancies 48
Pre-eclampsia: One name, two conditions - The case for early and late disease being different 47
Restricted physical activity and maternal rest improve fetal growth: should we look for the reason in the cardiovascular modifications? 47
Abnormal maternal cardiac function and morphology in pregnancies complicated by intrauterine fetal growth restriction 46
Maternal hemodynamics in early and late fetal growth restriction 44
Longitudinal maternal hemodynamic evaluation in uncomplicated twin pregnancies according to chorionicity: physiological cardiovascular dysfunction in monochorionic twin pregnancy 44
Maternal cardiac systolic and diastolic function: Relationship with uteroplacental resistances. A Doppler and echocardiographic longitudinal study 44
F4. NO donors and haemodynamic changes in fetal growth restriction 41
Left ventricular concentric geometry as a risk factor in gestational hypertension 40
Computerized evaluation of fetal heart rate during tocolytic treatment: Comparison between atosiban and ritodrine 38
NO donors on top of anti-hypertensive therapy reduces complications in chronic hypertensive pregnancies with hypodynamic circulation 37
Intrauterine growth restriction and fetal body composition 36
Low pregestational fat mass and subsequent maternal cardiovascular maladaptation in early pregnancy. The missing link for preeclampsia 36
Total vascular resistance and left ventricular morphology as screening tools for complications in pregnancy 35
L18. Total Vascular Resistance in complicated pregnancies 33
Maternal cardiovascular haemodynamics in normal and complicated pregnancies 30
Maternal diastolic dysfunction and left ventricular geometry in gestational hypertension 30
The cardiac-fetal-placental unit: fetal umbilical vein flow rate is linked to the maternal cardiac profile in fetal growth restriction 28
Maternal diastolic function in asymptomatic pregnant women with bilateral notching of the uterine artery waveform at 24 weeks' gestation: A pilot study 27
Nitric oxide donor increases umbilical vein blood flow and fetal oxygenation in fetal growth restriction: A pilot study 26
The role of umbilical vein blood flow assessment in the prediction of fetal growth velocity and adverse outcome: a prospective observational cohort study 25
ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction 22
Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome 21
Umbilical venous flow and maternal hemodynamics as predictors of impaired fetal growth in gestational diabetes: a prospective study 8
The impact of maternal cardiovascular status prior to labor on birth outcomes: an observational study 5
null 4
null 3
Totale 11.016
Categoria #
all - tutte 32.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.415


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021603 0 0 0 0 0 181 185 112 21 54 40 10
2021/2022305 13 57 16 14 12 10 17 13 14 38 24 77
2022/2023634 118 54 22 62 46 127 48 50 60 12 29 6
2023/2024236 19 3 7 9 11 70 14 7 4 10 2 80
2024/20252.140 21 202 112 55 17 358 259 116 202 117 390 291
2025/20261.579 238 143 368 366 342 122 0 0 0 0 0 0
Totale 11.016